160 related articles for article (PubMed ID: 7626311)
21. [Posttransplant regression of uremic tumoral calcinosis].
de Alarcón RM; Palomares M; Marfil A; Asensio C
Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
[TBL] [Abstract][Full Text] [Related]
22. [Calcinosis universalis with hyperphosphataemia--successful treatment with phosphorus deprivation].
Yoshikawa S; Shoji T; Ono A; Amagai H; Kamimaki Y; Takematsu H; Hosokawa O
Nihon Seikeigeka Gakkai Zasshi; 1985 Mar; 59(3):293-302. PubMed ID: 4020226
[TBL] [Abstract][Full Text] [Related]
23. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
Lyles KW; Halsey DL; Friedman NE; Lobaugh B
J Clin Endocrinol Metab; 1988 Jul; 67(1):88-92. PubMed ID: 3379139
[TBL] [Abstract][Full Text] [Related]
24. High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis.
Ichikawa S; Gray AK; Padgett LR; Reilly AM; Unsicker TR
J Bone Miner Res; 2014 Sep; 29(9):2017-23. PubMed ID: 24692172
[TBL] [Abstract][Full Text] [Related]
25. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.
Goldenstein PT; Neves PD; Balbo BE; Elias RM; Pereira AC; Onuchic LF; Jüppner H; Jorgetti V; Abensur H; Moysés RM
Am J Kidney Dis; 2018 Sep; 72(3):457-461. PubMed ID: 29548779
[TBL] [Abstract][Full Text] [Related]
26. Massive cerebral calcifications associated with increased renal phosphate reabsorption.
Weisinger JR; Mogollón A; Lander R; Bellorin-Font E; Riera R; Abadí I; Paz-Martínez V
Arch Intern Med; 1986 Mar; 146(3):473-7. PubMed ID: 3082304
[TBL] [Abstract][Full Text] [Related]
27. Primary hyperphosphatemic tumoral calcinosis: a case report.
Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
[TBL] [Abstract][Full Text] [Related]
28. Treatment of calcinosis circumscripta with probenecid.
Dent CE; Stamp TC
Br Med J; 1972 Jan; 1(5794):216-8. PubMed ID: 4621714
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Tumoral calcinosis: evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha,25-dihydroxycholecalciferol synthesis.
Zerwekh JE; Sanders LA; Townsend J; Pak CY
Calcif Tissue Int; 1980; 32(1):1-6. PubMed ID: 6775776
[TBL] [Abstract][Full Text] [Related]
31. [Hyperphosphatemic pseudotumoral calcinosis due to FGF23 mutation with secondary amyloidosis].
Sottini L; Veniero P; De Gaetano A; Olivi L; Brunori G
G Ital Nefrol; 2022 Aug; 39(4):. PubMed ID: 36073335
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus deprivation treatment of tumoral calcinosis.
Mozaffarian G; Nakhjavani MK; Hedayati MH; Shamekh S
Ann Intern Med; 1977 Jan; 86(1):120. PubMed ID: 835923
[No Abstract] [Full Text] [Related]
33. Regression of massive tumoral calcinosis of the ischium in a dialysis patient after treatment with reduced calcium dialysate and i.v. administration.
Apostolou T; Tziamalis M; Christodoulidou C; Fountas P; Billis A
Clin Nephrol; 1998 Oct; 50(4):247-51. PubMed ID: 9799070
[TBL] [Abstract][Full Text] [Related]
34. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in
Döneray H; Özden A; Gürbüz K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):239-243. PubMed ID: 33685073
[TBL] [Abstract][Full Text] [Related]
35. Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidism.
Vosik WM; Anderson CF; Steffee WP; Johnson WJ; Arnaud CD; Goldsmith RS
Mayo Clin Proc; 1972 Feb; 47(2):110-3. PubMed ID: 5010725
[No Abstract] [Full Text] [Related]
36. Hyperphosphatemia and tumoral calcinosis.
Wilber JF; Slatopolsky E
Ann Intern Med; 1968 May; 68(5):1043-9. PubMed ID: 4967214
[No Abstract] [Full Text] [Related]
37. [Calcinosis tumoralis. Pharmacological alternatives to surgical treatment and its etiological justification].
Gregosiewicz A; Warda E; Stołecka D; Kandzierski G
Chir Narzadow Ruchu Ortop Pol; 1989; 54(2):159-63. PubMed ID: 2625052
[TBL] [Abstract][Full Text] [Related]
38. [Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases].
Ben Taarit C; el Younsi F; Turki S; Mestiri M; Zlitni M; Ben Maïz H
Nephrologie; 2001; 22(7):349-52. PubMed ID: 11817212
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
Knox FG; Preiss J; Kim JK; Dousa TP
J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
[TBL] [Abstract][Full Text] [Related]
40. Tumoral calcinosis without hyperparathyroidism in a patient on continuous ambulatory peritoneal dialysis.
Gupta A; Sun Y; Konstantinov KN; Servilla KS; Hartshorne MF; Tzamaloukas AH
Adv Perit Dial; 2008; 24():132-6. PubMed ID: 18986017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
